Abstract:
Provided are an organometallic compound represented by Formula 1 and an organic light-emitting device including the same: M1(Ln1)n1(Ln2)3-n1 Formula 1 wherein, in Formula 1, Ln2 is a ligand represented by Formula 1A, and other substituents are the same as described in the detailed description of the present specification:
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 In Formula 1, M is a transition metal; L1 is a ligand represented by Formula 2 as disclosed herein; L2 is a monodentate ligand, a bidentate ligand, a tridentate ligand, or a tetradentate ligand; n1 is 1, 2, or 3, wherein, when n1 is 2 or greater, two or more ligands L1 are identical to or different from each other; n2 is 0, 1, 2, 3, or 4, wherein, when n2 is 2 or greater, two or more ligands L2 are identical to or different from each other; and L1 and L2 are different from each other.
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, L11, M, R11 to R17, m, and n are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: Ir(L1)n(L2)(3-n) Formula 1 wherein in Formula 1, L1, L2, and n are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein, in Formula 1, L1 is a ligand represented by Formula 2, L2 is a ligand represented by one of Formulae 3 to 5, and n1 and n2 are each independently 1 or 2, wherein Formulae 1 to 5 are described in the specification.
Abstract:
An organometallic compound represented by Formula 1:
M1(L1)n1(L2)n2 Formula 1
wherein, M1 is a transition metal, L1 is ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2:
wherein X1 to X4 are each independently C or N; Y1 is O, S, Se, C(R5)(R6), N(R7), or Si(R8)(R9); ring CY2 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; ring CY3 is a 5-membered heterocyclic group, a 5-membered heterocyclic group condensed with a C5-C30 carbocyclic group, or a 5-membered heterocyclic group condensed with a C1-C30 heterocyclic group; * and *′ each indicate a binding site to M1; and the remaining descriptions of Formulae 1A and 2B as described herein.
Abstract:
An organometallic compound represented by Formula 1:
M1(L1)n1(L2)n2 Formula 1
wherein, M1 is a transition metal, L1 is a ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, n1 and n2 are each independently 1 or 2, Formula 1A Formula 1B
wherein X1 to X4 are each independently C or N, rings CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, Z1 and Z2 are each independently Si(Q1)(Q2)(Q3) or —Ge(Q1)(Q2)(Q3), provided that each of Z1 and Z2 is not —SiH3, a1 and a2 are each independently an integer from 0 to 10, a sum of a1 and a2 is 1 or greater, Y1 and Y2 are each independently O, S, Se, or C(R5)(R6), * and *′ each indicates a binding site to M1, and R1 to R3, R5, R6, and R41 to R48 are as described herein.
Abstract:
An organometallic compound represented by Formula 1:
M1(Ln1)n1(Ln2)n2 Formula 1
wherein M1 is a transition metal, Ln1 is a ligand represented by Formula 1A, Ln2 is a ligand represented by Formula 1B, n1 is 1 or 2, and n2 is 1 or 2,
wherein ring CY1 and ring CY2 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group, ring CY41 is a phenyl group, ring CY42 is a 5-membered aromatic heterocyclic group, and the other substituents are as described herein.
Abstract:
An organometallic compound represented by Formula 1:
M1(Ln1)n1(Ln2)n2
wherein, in Formula 1, M1 is a transition metal; Ln1 is a ligand represented by Formula 1A; Ln2 is a ligand represented by Formula 1B; n1 is 1 or 2; and n2 is 1 or 2,
wherein X1 is C or N, X2 is C or N, Y2 is O or S, and the other substituents are as described in the detailed description.